01 May 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:41 PM
Alembic Pharmaceuticals Ltd.

BSE

  • 625.90 16.85 (2.77%)
  • Vol: 10601
  • BSE Code: 533573
  • PREV. CLOSE
    609.05
  • OPEN PRICE
    601.00
  • BID PRICE (QTY.)
    623.65(25)
  • OFFER PRICE (QTY.)
    0.00(0)

NSE

  • 627.45 0.00 (0%)
  • Vol: 102983
  • NSE Code: APLLTD
  • PREV. CLOSE
    627.45
  • OPEN PRICE
    605.95
  • BID PRICE (QTY.)
    627.45(2222)
  • OFFER PRICE (QTY.)
    0.00(0)

Alembic Pharmaceuticals Ltd. Quarterly Results

Quarters
Select year
(Rs.in Million)
Particulars
Dec 2016
Sep 2016
Jun 2016
Mar 2016
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
7707.40
8722.50
7280.40
6265.70
Total Expenditure
6253.40
6944.80
5710.80
4832.70
PBIDT (Excl OI)
1454.00
1777.70
1569.60
1433.00
Other Income
1.60
5.00
3.90
26.20
Operating Profit
1455.60
1782.70
1573.50
1459.20
Interest
7.50
9.60
10.70
13.00
Exceptional Items
NA
NA
NA
NA
PBDT
1448.10
1773.10
1562.80
1446.20
Depreciation
211.30
206.20
193.80
244.00
Profit Before Tax
1236.80
1566.90
1369.00
1202.20
Tax
392.80
331.50
332.70
285.90
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
843.90
1235.40
1036.30
916.30
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
843.90
1235.40
1036.30
916.30
Minority Interest
NA
NA
NA
NA
Shares of Associates
21.5
-37.1
1.1
-4.5
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
865.50
1198.30
1037.40
911.80
Equity Capital
377.00
377.00
377.00
377.00
Face Value (IN RS)
2.00
2.00
2.00
2.00
Reserves
NA
NA
NA
NA
Basic Eps After Extraordinary Items
4.59
6.36
5.41
4.84
Basic Eps Before Extraordinary Items
4.59
6.36
5.41
4.84
No of Public Share Holdings
51508769.00
48353779.00
48777294.00
48777294.00
% of Public Share Holdings
27.32
25.65
25.87
25.87
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
18.86
20.38
21.56
22.87
PBIDTM%
18.89
20.44
21.61
23.29
PBDTM%
18.79
20.33
21.47
23.08
PBTM%
16.05
17.96
18.80
19.19
PATM%
10.95
14.16
14.23
14.62
 
Notes
Notes
Notes
Notes